Literature DB >> 15848073

Use of human germline genes in a CDR homology-based approach to antibody humanization.

William Ying Khee Hwang1, Juan Carlos Almagro, Timothy N Buss, Philip Tan, Jefferson Foote.   

Abstract

We report a new method of humanizing antibodies by complementarity determining region (CDR) grafting. Our method differs from others in that we choose human framework sequences from the set of human germline genes based on the structural similarity of the human CDRs to those of the mouse antibody to be humanized. The structural similarity is evaluated by scoring residue-to-residue homology of the mouse CDRs to human candidates with the same Chothia canonical structures. The method is illustrated with the humanization of the anti-lysozyme antibody D1.3.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848073     DOI: 10.1016/j.ymeth.2005.01.004

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  28 in total

Review 1.  Molecular engineering of antibodies for therapeutic and diagnostic purposes.

Authors:  Frédéric Ducancel; Bruno H Muller
Journal:  MAbs       Date:  2012-07-01       Impact factor: 5.857

2.  A novel class of anti-IL-12p40 antibodies: potent neutralization via inhibition of IL-12-IL-12Rβ2 and IL-23-IL-23R.

Authors:  Adam W Clarke; Lynn Poulton; Hoi Yi Wai; Stuart A Walker; Shanti David Victor; Teresa Domagala; Dragana Mraovic; Danyal Butt; Nina Shewmaker; Philip Jennings; Anthony G Doyle
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

3.  Antibody humanization by structure-based computational protein design.

Authors:  Yoonjoo Choi; Casey Hua; Charles L Sentman; Margaret E Ackerman; Chris Bailey-Kellogg
Journal:  MAbs       Date:  2015-08-07       Impact factor: 5.857

4.  Production of a germline-humanized cetuximab scFv and evaluation of its activity in recognizing EGFR- overexpressing cancer cells.

Authors:  Arsham Banisadr; Yaghoub Safdari; Anvarsadat Kianmehr; Mahdieh Pourafshar
Journal:  Hum Vaccin Immunother       Date:  2017-12-21       Impact factor: 3.452

Review 5.  Engineering the variable region of therapeutic IgG antibodies.

Authors:  Tomoyuki Igawa; Hiroyuki Tsunoda; Taichi Kuramochi; Zenjiro Sampei; Shinya Ishii; Kunihiro Hattori
Journal:  MAbs       Date:  2011-05-01       Impact factor: 5.857

6.  Atypical antigen recognition mode of a shark immunoglobulin new antigen receptor (IgNAR) variable domain characterized by humanization and structural analysis.

Authors:  Oleg V Kovalenko; Andrea Olland; Nicole Piché-Nicholas; Adarsh Godbole; Daniel King; Kristine Svenson; Valerie Calabro; Mischa R Müller; Caroline J Barelle; William Somers; Davinder S Gill; Lidia Mosyak; Lioudmila Tchistiakova
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

7.  Computationally driven antibody engineering enables simultaneous humanization and thermostabilization.

Authors:  Yoonjoo Choi; Christian Ndong; Karl E Griswold; Chris Bailey-Kellogg
Journal:  Protein Eng Des Sel       Date:  2016-06-21       Impact factor: 1.650

8.  Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody.

Authors:  James R Apgar; Michelle Mader; Rita Agostinelli; Susan Benard; Peter Bialek; Mark Johnson; Yijie Gao; Mark Krebs; Jane Owens; Kevin Parris; Michael St Andre; Kris Svenson; Carl Morris; Lioudmila Tchistiakova
Journal:  MAbs       Date:  2016-09-13       Impact factor: 5.857

9.  Frontier of therapeutic antibody discovery: The challenges and how to face them.

Authors:  Zhi-Jian Lu; Su-Jun Deng; Da-Gang Huang; Yun He; Ming Lei; Li Zhou; Pei Jin
Journal:  World J Biol Chem       Date:  2012-12-26

10.  Germline humanization of a murine Abeta antibody and crystal structure of the humanized recombinant Fab fragment.

Authors:  Remy Robert; Victor A Streltsov; Janet Newman; Lesley A Pearce; Kim L Wark; Olan Dolezal
Journal:  Protein Sci       Date:  2010-02       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.